Renuvion® for Facial Renewal

renuvion-banner-update_1920x1080_1-3_fda_fr-4

Apyx Medical Receives FDA Clearance for use
of Renuvion in Wrinkle Reduction Procedures.

In a marketplace long-dominated by laser treatments, true innovation has been scarce. Renuvion is different, and it’s the first major advancement in decades of skin treatments for the face. Renuvion for Facial Renewal – taking transformation to a whole new level.

Having received this expanded 510K clearance, the Renuvion Dermal handpiece is now indicated for dermatological procedures for the treatment of moderate to severe wrinkles and rhytides, for patients with Fitzpatrick skin types I, II or III. A Facial Renewal procedure is performed using the same Renuvion generator currently on the market with the addition of the new Dermal handpiece specifically designed for this application.

Renuvion for Facial Renewal leverages the same helium plasma and proprietary RF technology that has been used in the plastic surgery space for years.

Real Renewal

Results from IDE Clinical Study using a single-pass technique.1

Before

6 Months Post-Op

Patient: 55-year-old female

Before

6 Months Post-Op

Patient: 58-year-old female

Before

6 Months Post-Op

Patient: 54-year-old male

Before

6 Months Post-Op

Patient: 63-year-old female

Before

6 Months Post-Op

Patient: 61-year-old female

We are excited to bring this product to providers across the United States over the coming months. Please stay tuned for more information on how Renuvion for Facial Renewal is bringing transformation to a whole new level.

Ready to Learn More?

The Renuvion Dermal Handpiece is indicated for dermatological procedures for the treatment of moderate to severe wrinkles and rhytides, limited to patients with Fitzpatrick skin types I, II, or III.

Warning: Application of more than one treatment pass in the perioral area, on the forehead, and along the jawline has been associated with hypertrophic scarring.

Risks associated with the use of the Renuvion Dermal System include but are not limited to hypertrophic scarring, milia/acne, telangiectasia (spider veins), skin discoloration/hypopigmentation, dormant infection reactivation, infection, bruising or bleeding. As with any procedure, individual results may vary. As with all energy devices there are inherent risks associated with its use, refer to the IFU for further information.

Reference:

Holcomb, J.D., Kelly, M., Hamilton, T.K. and DeLozier, J.B., III (2020), A Prospective Study Evaluating the Use of Helium Plasma for Dermal Resurfacing. Lasers Surg Med, 52: 940-951. https://doi.org/10.1002/lsm.23257